Large-scale testing (Phase 3)Study completedNCT02382939
What this trial is testing
A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
Who this might be right for
Adult Growth Hormone DeficiencyGrowth Hormone Disorder
Novo Nordisk A/S 92